weight loss with compounded semaglutide GLP-1 Options Semaglutide Injections Kirkland & Bellevue

A 2025 Cell Metabolism analysis noted that lean mass loss on GLP-1 receptor agonists has raised genuine questions about the long-term metabolic implications particularly for people already experiencing age-related muscle decline

A build-up of these cells can contribute to inflammation and tissue dysfunction

However, they stressed that the findings show only positive links not established evidence of safety or therapeutic benefit during or before pregnancy

Standard titration schedule week by week Tirzepatide follows a structured dose escalation that builds tolerance gradually

The Phase 2 trial published in the New England Journal of Medicine in 2023 provides the clearest picture of its effects